FDA panel blesses GSK, Theravance COPD drug

Theravance Inc. and partner GlaxoSmithKline plc won an important victory Tuesday as a Food and Drug Administration advisory panel said the companies' experimental once-a-day drug for COPD patients recommended that the treatment be approved...